Samsung Pharmaceutical Industry Corp Ltd (001360) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Samsung Pharmaceutical Industry Corp Ltd (Samsung Pharm) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The companys products include prescription drugs, over the counter drugs, healthcare food, healthcare energy drinks and insecticides. It offers anticancer immunotherapy agent, antipyretic analgestic and antiinflammatory agents, skeletal muscle relaxant, antiobesity agents, hypotensive agents,antophlegm agents, anti-spasticenzyme agent and ostepoposis agent, among others. Samsung Pharm also offers medicines for digestive system, medicines for liver disorder, nutritional supplements and health tonic, among others. The company markets its products through its distribution network. It operates in Hwaseong, Busan, Daegu, Daejon, Gwangju, Jeonju and Seoul, South Korea. Samsung Pharma is headquartered in Hwaseong, South Korea.
Samsung Pharmaceutical Industry Corp Ltd (001360) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Samsung Pharmaceutical Industry Corp Ltd (Samsung Pharm) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The companys products include prescription drugs, over the counter drugs, healthcare food, healthcare energy drinks and insecticides. It offers anticancer immunotherapy agent, antipyretic analgestic and antiinflammatory agents, skeletal muscle relaxant, antiobesity agents, hypotensive agents,antophlegm agents, anti-spasticenzyme agent and ostepoposis agent, among others. Samsung Pharm also offers medicines for digestive system, medicines for liver disorder, nutritional supplements and health tonic, among others. The company markets its products through its distribution network. It operates in Hwaseong, Busan, Daegu, Daejon, Gwangju, Jeonju and Seoul, South Korea. Samsung Pharma is headquartered in Hwaseong, South Korea.
Samsung Pharmaceutical Industry Corp Ltd (001360) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
3
List of Tables 4
List of Figures 4
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Samsung Pharma to Raise USD34 Million in Rights Offering of Shares 10
Debt Offering 11
Samsung Pharma Completes Public Offering Of Convertible Bonds Due 2014 For US$0.86 Million 11
Samsung Pharma Completes Public Offering Of Unsecured Bonds Due 2014 For US$7 Million 12
Samsung Pharmaceutical Industry Corp Ltd - Key Competitors 13
Samsung Pharmaceutical Industry Corp Ltd - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15
List Of Tables
List of TablesSamsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Samsung Pharmaceutical Industry Corp Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Samsung Pharmaceutical Industry Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Samsung Pharma to Raise USD34 Million in Rights Offering of Shares 10
Samsung Pharma Completes Public Offering Of Convertible Bonds Due 2014 For US$0.86 Million 11
Samsung Pharma Completes Public Offering Of Unsecured Bonds Due 2014 For US$7 Million 12
Samsung Pharmaceutical Industry Corp Ltd, Key Competitors 13
Samsung Pharmaceutical Industry Corp Ltd, Other Locations 14
RELATED REPORTS
Samsung Biologics Performance Capabilities Goals Strategies
This report is part of the Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the development
View ReportSamsung Biologics Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The companys business activities includes process development, contract manufacturing, aseptic fill and finish and project management. Its
View Report2022 Tilray Half-Year Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the
View Report2022 Green Thumb Half-Year Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
